Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 675 of 1863 entries
View as:

Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase: N/A Priority: Normal
NCT ID: NCT00736619 Org: User:
Start: 08/31/08 End: 08/31/16 Due: 08/31/17

Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00002471 Org: User:
Start: 02/28/90 End: 01/31/03 Due: 01/31/04

Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00471601 Org: User:
Start: 03/13/07 End: 12/22/23 Due: 12/22/24

Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005070 Org: User:
Start: 01/31/00 End: 05/31/01 Due: 05/31/02

Molecular Studies and Clinical Correlations in Human Prostatic Disease

Phase: N/A Priority: Normal
NCT ID: NCT00578240 Org: User:
Start: 04/30/90 End: 12/31/25 Due: 12/31/26

Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)

Phase: N/A Priority: Normal
NCT ID: NCT05561842 Org: User:
Start: 09/21/22 End: 09/21/27 Due: 09/21/28

Meaning-Centered Psychotherapy at Home

Phase: N/A Priority: Normal
NCT ID: NCT05495737 Org: User:
Start: 08/08/22 End: 08/08/25 Due: 08/08/26

Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03179917 Org: User:
Start: 06/08/17 End: 06/30/26 Due: 06/30/27

Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02139150 Org: User:
Start: 05/31/14 End: 05/31/20 Due: 05/31/21

Determinants of Bladder Cancer Recurrence Study (The DETER Study)

Phase: N/A Priority: Normal
NCT ID: NCT02400944 Org: User:
Start: 03/31/15 End: 03/31/26 Due: 03/31/27

A Study of Ivonescimab in People With Endometrial and Cervical Cancers

Phase: N/A Priority: Normal
NCT ID: NCT06925724 Org: User:
Start: 04/04/25 End: 04/04/27 Due: 04/04/28

Early Onset and Familial Gastric Cancer Registry

Phase: N/A Priority: Normal
NCT ID: NCT00582257 Org: User:
Start: 12/13/05 End: 09/30/24 Due: 09/30/25

Using Urine Samples to Identify Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06033248 Org: User:
Start: 08/24/23 End: 08/31/26 Due: 08/31/27

Sexual Functioning After Primary Treatment of Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00596544 Org: User:
Start: 11/30/04 End: 11/30/15 Due: 11/30/16

MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

Phase: N/A Priority: Normal
NCT ID: NCT06954337 Org: User:
Start: 04/22/25 End: 04/30/27 Due: 04/30/28

Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00675597 Org: User:
Start: 05/31/08 End: 02/29/12 Due: 02/28/13

A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT03556332 Org: User:
Start: 07/02/18 End: 07/31/26 Due: 07/31/27

Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT

Phase: N/A Priority: Normal
NCT ID: NCT01931150 Org: User:
Start: 08/31/13 End: 09/30/15 Due: 09/30/16

Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma

Phase: N/A Priority: Normal
NCT ID: NCT00588523 Org: User:
Start: 09/30/02 End: 02/02/23 Due: 02/02/24

Comparing Distress Screening + Consultation With Enhanced Usual Care for Caregivers of Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03856086 Org: User:
Start: 02/25/19 End: 02/28/26 Due: 02/28/27

Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005806 Org: User:
Start: 09/30/99 End: 03/31/02 Due: 03/31/03

Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01354951 Org: User:
Start: 05/31/11 End: 10/06/17 Due: 10/06/18

A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05778825 Org: User:
Start: 03/10/23 End: 03/31/26 Due: 03/31/27

Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00004922 Org: User:
Start: 06/30/99 End: 06/30/02 Due: 06/30/03

Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00003341 Org: User:
Start: 12/31/97 End: 09/30/03 Due: 09/30/04